Active surveillance may be an alternative to surgery for localized renal tumors

Share this content:

the ONA take:

According to a recent study published in The Journal of Urology, in patients likely to have surgery for kidney cancer, close monitoring of small renal tumors is associated with low rates of cancer growth or mortality.

The standard of care for patients with tumors confined to the kidneys is surgical excision, but in ill or elderly patients, the risk of surgical complications may outweigh the benefits.

For the study, researchers identified 68 patients with clinically localized renal tumors. Of those 45 patients received active surveillance while 23 progressed to intervention. Results showed that localized renal tumors 4cm or greater in diameter showed growth rates similar to those of small tumors managed with active surveillance.

In addition, there was a low rate of progression to metastatic disease at short-term follow-up that was comparable in both groups.

The findings suggest that close monitoring of clinically localized renal tumors may provide an alternative to surgery in order to avoid certain complications that may arise in special populations.

Adrenalectomy Rates Remain High in Radical Nephrectomy
In patients likely to have surgery, close monitoring of small renal tumors is associated with low rates of cancer growth or mortality.
Although surgical excision of tumors remains the standard of care for renal tumors that have not yet spread (localized), the risk of complications in elderly or ill patients may outweigh the benefits of surgery. The study suggests that actively monitoring renal tumors in some patients may prove a safer option than immediate surgery.
READ FULL ARTICLE From Medical Express
You must be a registered member of ONA to post a comment.

Sign Up for Free e-newsletters

Regimen and Drug Listings


Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs